Cytosorbents Corporation (CTSO) News
Follow Cytosorbents Corporation (CTSO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Cytosorbents Q3'26 Earnings Preview Includes EPS Estimate of (0.90) USD
Cytosorbents is set to report Q3'26 results on October 29; the release time is not specified. EPS is expected at (0.90) USD.
EQUITY | Oct 28, 2026, 11:05 AM UTC
L
CytoSorbents regains Nasdaq $1.00 minimum bid compliance; MVLS shortfall remains under review
CytoSorbents regained compliance with Nasdaq's $1.00 minimum bid price requirement after 10 consecutive trading days at or above $1.00.Key Highlights:Original SEC Filing: Cytosorbents Corp [ CTSO ] - 8-K - Sep. 23, 2026T
REGULATION | Sep 23, 2026, 11:35 AM UTC
L
CytoSorbents Regains Compliance With Nasdaq Minimum Bid Price Requirement
CytoSorbents Regains Compliance With Nasdaq Minimum Bid Price Requirement
NEWS | Sep 23, 2026, 11:03 AM UTC
L
CTSO - CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement
CTSO - CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement
NEWS | Sep 23, 2026, 11:01 AM UTC
L
CTSO - CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
CTSO - CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 10, 2026, 11:01 AM UTC
L
CytoSorbents to present at Moody Capital Solutions 2026 conference
CytoSorbents Corporation NASDAQ:CTSO said it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference.
EQUITY | Sep 04, 2026, 01:16 PM UTC
L
Cytosorbents plans stock split to meet Nasdaq $1 bid requirement
Cytosorbents plans a split intended to increase per-share trading price to help satisfy Nasdaq’s $1 minimum bid price requirement for continued listing.
EQUITY | Sep 03, 2026, 11:01 AM UTC
M
CytoSorbents (CTSO) announces new real-world CABG bleeding data
CytoSorbents said new real-world data show a significant reduction in severe bleeding using CytoSorb in CABG patients on ticagrelor. It also updated DrugSorb-ATR FDA pre-submission meetings.
REGULATION | Sep 02, 2026, 11:30 AM UTC